Literature DB >> 8133143

The ret/PTC oncogene in papillary thyroid carcinoma.

S M Jhiang1, E L Mazzaferri.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1994        PMID： 8133143

Source DB:  PubMed          Journal:  J Lab Clin Med        ISSN： 0022-2143


× No keyword cloud information.
  22 in total

Review 1.  Expression patterns of cellular growth-controlling genes in non-medullary thyroid cancer: basic aspects.

Authors:  N J Sarlis
Journal:  Rev Endocr Metab Disord       Date:  2000-04       Impact factor: 6.514

Review 2.  The role of immunohistochemical markers in the diagnosis of follicular-patterned lesions of the thyroid.

Authors:  Sylvia L Asa
Journal:  Endocr Pathol       Date:  2005       Impact factor: 3.943

3.  Sorafenib potently inhibits papillary thyroid carcinomas harboring RET/PTC1 rearrangement.

Authors:  Ying C Henderson; Soon-Hyun Ahn; Ya'an Kang; Gary L Clayman
Journal:  Clin Cancer Res       Date:  2008-08-01       Impact factor: 12.531

4.  BAC-FISH assays delineate complex chromosomal rearrangements in a case of post-Chernobyl childhood thyroid cancer.

Authors:  Johnson Kwan; Adolf Baumgartner; Chun-Mei Lu; Mei Wang; Jingly F Weier; Horst F Zitzelsberger; Heinz-Ulrich G Weier
Journal:  Folia Histochem Cytobiol       Date:  2009       Impact factor: 1.698

5.  MEK inhibitor PD0325901 significantly reduces the growth of papillary thyroid carcinoma cells in vitro and in vivo.

Authors:  Ying C Henderson; Yunyun Chen; Mitchell J Frederick; Stephen Y Lai; Gary L Clayman
Journal:  Mol Cancer Ther       Date:  2010-06-29       Impact factor: 6.261

6.  High prevalence of RET tyrosine kinase activation in Mexican patients with papillary thyroid carcinomas.

Authors:  I Martínez; A Mantilla; M E Medrano; R Hernández; D M Hernández; M Lazos; H Santiago; B González; A Hidalgo; M Salcedo
Journal:  Endocr Pathol       Date:  2001       Impact factor: 3.943

7.  High rate of BRAF and RET/PTC dual mutations associated with recurrent papillary thyroid carcinoma.

Authors:  Ying C Henderson; Thomas D Shellenberger; Michelle D Williams; Adel K El-Naggar; Mitchell J Fredrick; Kathleen M Cieply; Gary L Clayman
Journal:  Clin Cancer Res       Date:  2009-01-15       Impact factor: 12.531

8.  Kinase expression and chromosomal rearrangements in papillary thyroid cancer tissues: investigations at the molecular and microscopic levels.

Authors:  H-U G Weier; J Kwan; C-M Lu; Y Ito; M Wang; A Baumgartner; S W Hayward; J F Weier; H F Zitzelsberger
Journal:  J Physiol Pharmacol       Date:  2009-10       Impact factor: 3.011

9.  Inhibition of the growth of papillary thyroid carcinoma cells by CI-1040.

Authors:  Ying C Henderson; Soon-Hyun Ahn; Gary L Clayman
Journal:  Arch Otolaryngol Head Neck Surg       Date:  2009-04

10.  Fine-needle aspiration biopsy of thyroid nodules: impact on clinical practice.

Authors:  R V García-Mayor; L F Pérez Mendez; C Páramo; R Luna Cano; A Rego Iraeta; M Regal; J M Sierra; E Fluiters
Journal:  J Endocrinol Invest       Date:  1997-09       Impact factor: 4.256
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.